What's Happening?
The University of North Carolina at Chapel Hill has established Carolina’s Regional Emerging Special Pathogens Treatment Center (RESPTC), a specialized facility designed to isolate and treat patients infected with deadly pathogens like the Ebola virus.
More than 70 medical professionals have undergone extensive training to provide care while ensuring the safety of healthcare personnel and other patients. Co-led by Dr. William Fischer II, Dr. David Wohl, and program manager Brooke Brewer, the center is a collaborative effort with UNC Health colleagues. In 2022, Carolina became one of 13 centers nationwide funded by the U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response. Dr. Fischer, who leads emerging pathogens research for the UNC Institute for Global Health and Infectious Diseases, emphasized that UNC's decade of experience in treating and researching dangerous infectious diseases has equipped them to prepare for future outbreaks. The center has developed a protocol for handling suspected cases, starting with clinicians contacting the state health department's on-call epidemiologist, followed by a joint assessment with RESPTC staff to determine if isolation at Carolina is necessary.
Why It's Important?
The establishment of Carolina’s Regional Emerging Special Pathogens Treatment Center is a critical development for U.S. public health and national security. While deadly viruses like Ebola are not endemic to the United States, their potential to travel internationally due to incubation periods of up to 21 days poses a significant threat. This center enhances the nation's preparedness to manage imported cases, preventing potential widespread outbreaks and protecting the public. The specialized training of over 70 medical professionals ensures that high-level care can be provided safely, mitigating risks to healthcare workers—a lesson learned from past outbreaks. Furthermore, UNC's focus on turning field experience into stronger preparedness efforts for the state, region, and nation contributes to a more resilient healthcare infrastructure. This initiative also highlights the importance of federal funding, such as that from the U.S. Department of Health and Human Services, in building and maintaining specialized medical capabilities essential for responding to global health threats that could impact the U.S.
What's Next?
The RESPTC team will continue to refine its protocols and expand its capabilities, including building a neonatal team to address the needs of all patient populations. The center's ongoing research into emerging pathogens will contribute to a deeper understanding of these diseases and the development of more effective treatments. The established protocol for handling suspected cases, involving collaboration between clinicians, the state health department, and RESPTC, will be continuously tested and improved. This includes a planned eight-hour lead time for patient arrival after notification from ASPR or state public health authorities. The center's efforts will also involve continued collaboration with other national centers funded by the U.S. Department of Health and Human Services to share best practices and coordinate responses to potential outbreaks. The focus will remain on maintaining a high level of readiness to respond to any high-consequence infectious disease that may emerge or be introduced into the U.S.
Beyond the Headlines
The creation of centers like RESPTC reflects a broader shift in U.S. public health strategy towards proactive preparedness for global health threats. The increasing frequency and urbanicity of infectious disease outbreaks worldwide necessitate a robust domestic response capability, even for pathogens not typically found in the U.S. This initiative underscores the understanding that in an interconnected world, a health crisis anywhere can quickly become a health crisis everywhere. The emphasis on specialized training and dedicated facilities also highlights the ethical responsibility to protect healthcare workers who are on the front lines of these dangerous situations. Furthermore, the integration of research with clinical care at UNC-Chapel Hill demonstrates the critical role of academic institutions in advancing both treatment protocols and public health policy. This model of preparedness could serve as a blueprint for other regions, fostering a more resilient national and international defense against future pandemics and epidemics.
